Pluvicto prostate cancer therapy vanchcs
Ended Awarded Last action
- Contract number
- 36C26125F0002
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,693,772
Award facts
- Contract value 100% obligated
- $1,693,772.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$464,441 | |
| Supplemental Agreement for work within scope | -$1,030,103 | |
| Supplemental Agreement for work within scope | -$1,182,083 | |
| Original award | $4,370,400 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary headquartered in Millburn, New Jersey, received a delivery order valued at $1.69M from Veterans Integrated Service Network 21 (VISN 21) for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), a targeted radioligand therapy used in prostate cancer treatment. The delivery order, awarded October 1, 2024, under the firm fixed-price contract mechanism with a completion date of September 30, 2025, represents a quantity decrease from prior clinical authorization (CLIN 0002) and will be performed at the contractor's Millburn, New Jersey facility. This award is issued without small business set-aside designation and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), the standard procurement vehicle for specialized radiopharmaceutical products across the Department of Veterans Affairs.
This delivery order is part of a larger $7.5M blanket purchase agreement between VISN 21 and Advanced Accelerator Applications USA Inc. for PLUVICTO and LUTATHERA products through February 15, 2026. The Department of Veterans Affairs has established Advanced Accelerator Applications USA Inc. as a premier supplier of radiopharmaceuticals across multiple Veterans Integrated Service Networks, with the contractor maintaining a substantial portfolio of BPAs and indefinite delivery contracts exceeding $120M in total value. The vendor supplies critical diagnostic and therapeutic nuclear medicine products to support VA medical center oncology and imaging programs nationwide.
Quick answers
Who was awarded contract 36C26125F0002?
36C26125F0002 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26125F0002 worth?
The government has obligated $1,693,772 on 36C26125F0002.
Is contract 36C26125F0002 an order under another contract?
Yes. 36C26125F0002 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125F0002 competed?
The extent of competition for 36C26125F0002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award